Allegra Medical Technologies Limited

Equities

AMT

AU000000AMT8

Medical Equipment, Supplies & Distribution

Market Closed - Australian S.E. Other stock markets 05:10:21 13/02/2024 GMT			5-day change	1st Jan Change
0.029 ^AUD	+26.09%		-.--%	-35.56%

03-22	Allegra Medical Technologies Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI
03-11	Trading in Allegra Medical Technologies' Stock Could Resume on March. 25	MT

Allegra Orthopaedics : Company Update – Innovation Division Shareholder Presentation August 2023

August 03, 2023 at 02:25 am

Company Update - Innovation Division Shareholder Presentation August 2023

Attachments

Original Link
Original Document
Permalink

Disclaimer

Allegra Orthopaedics Limited published this content on 03 August 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 August 2023 01:24:09 UTC.

Latest news about Allegra Medical Technologies Limited

Allegra Medical Technologies Limited Reports Earnings Results for the Half Year Ended December 31, 2023	03-22	CI
Trading in Allegra Medical Technologies' Stock Could Resume on March. 25	03-11	MT
Allegra Medical Technologies Pulls Out of FDA Submission for Spinal Cage Device	02-06	MT
Allegra Orthopaedics Files Informal Response to US FDA Request for Spinal Cage Implant Application	12-05	MT
Allegra Medical Technologies Completes Name Change	11-02	MT
Allegra Orthopaedics Establishes Submission Timeline for US FDA Request on Spinal Cage Application	29/09/23	MT
Allegra Orthopaedics Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23	CI
Robinwood Investment Pty Limited completed the acquisition of All business assets of Orthopedics Division from Allegra Orthopaedics Limited.	27/08/23	CI
Robinwood Investment Pty Limited has entered into a binding agreement to acquire All business assets of Orthopedics Division from Allegra Orthopaedics Limited for AUD 4 million.	01/05/23	CI
Allegra Orthopaedics Files US FDA Submission for Implantable Spinal Cage Device	31/03/23	MT
Allegra Orthopaedics Limited Reports Earnings Results for the Half Year Ended December 31, 2022	24/02/23	CI
Allegra Orthopaedics Completes Large Animal Study for Spinal Cage Project	22/02/23	MT
Allegra Orthopaedics Limited Announces Positive Results Upon Completion of the Large Animal Sheep Study	21/02/23	CI
Allegra Orthopaedics Limited Reports Earnings Results for the Full Year Ended June 30, 2022	26/08/22	CI
Allegra Orthopaedics Limited Reports Earnings Results for the Half Year Ended December 31, 2021	24/02/22	CI
Allegra Orthopaedics Limited Announces Resignation of Anthony Hartnell as Director	07/02/22	CI
Allegra Orthopaedics Limited Announces Change of Company Secretary	04/02/22	CI
Allegra Orthopaedics Limited Announces Large Animal Study Shows Positive Results	31/01/22	CI
Allegra Orthopaedics Expects Surgery Restrictions to Impact Fiscal Year Earnings	19/01/22	MT
Allegra Orthopaedics Limited Provides Earnings Guidance for the Full Year 2022	18/01/22	CI
Allegra Orthopaedics Limited Reports Earnings Results for the Full Year Ended June 30, 2021	26/08/21	CI
Allegra Orthopaedics Limited Announces Improving Coating Techniques for Orthopaedic Implants	09/08/21	CI
Allegra Orthopaedics Limited announced that it expects to receive AUD 2 million in funding from Robinwood Investment Pty Limited	27/04/21	CI
Allegra Orthopaedics Limited Engages Robert Bell to Lead the Technology and Innovation Division	19/04/21	CI
Allegra Orthopaedics : Completes Pilot Animal Study for Spinal Cage Device	06/04/21	MT

Chart Allegra Medical Technologies Limited

Duration

Period

Chart Allegra Medical Technologies Limited

More charts

Company Profile

Allegra Medical Technologies Limited, formerly Allegra Orthopaedics Limited, is a biotechnology company. The Company is engaged in the medical device industry with its pioneering three dimensional (3D)-printed Sr-HT and Sr-HT-Gahnite orthopedic devices. It holds exclusive ownership of bio ceramic material, along with registered patents and patent applications from the University of Sydney. This material has several applications, including its use as a cervical fusion cage in spinal surgery, offering treatment options for patients. The Company is developing Sr-HT ceramic material to demonstrate the bioactivity required for bone regeneration. Sr-HT-Gahnite features bioactivity, biocompatibility, and mechanical properties suitable for load- bearing orthopedic implants. The primary focus centers on commercializing the Sr-HT Gahnite Bone substitute.

Sector

Medical Equipment, Supplies & Distribution

Calendar

29/08/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ALLEGRA MEDICAL TECHNOLOGIES LIMITED	-35.56%	2.3M
ABBOTT LABORATORIES	-5.31%	182B
MEDTRONIC PLC	-1.21%	114B
BECTON, DICKINSON AND COMPANY	-5.53%	67.76B
DEXCOM, INC.	+1.22%	51.91B
CENCORA, INC.	+7.03%	43.23B
HOYA CORPORATION	+6.07%	41.07B
METTLER-TOLEDO INTERNATIONAL, INC.	+21.96%	32.07B
TERUMO CORPORATION	+15.86%	25B
ZIMMER BIOMET HOLDINGS, INC.	-4.81%	24.55B

Other Medical Equipment, Supplies & Distribution